Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd Covalent Drug Discovery and Development Summit

Evvnt Promotion / evvnt
-
10.12.2024 - 12.12.2024  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Temi della conferenza
Uniting Large Pharma, Innovative Biotech and Leading Academics to Eliminate the Boundaries of Druggability with Novel Covalent Drugs

With continued advancements in screening platforms and proteomics, the covalency renaissance continues as biopharma race to unlock hard-to-target proteins across oncology, immunology and CNS. We are witnessing this industry make great strides in utilizing novel covalent modalities and elucidating novel warheads to target amino acids beyond cysteine.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2537785-3?pid=4832

Speakers: Adam Cotton -Associate - Novartis Venture Fund, Andrea Zuhl -Vice President, Chemical Biology and Proteomics - HYKU Biosciences, and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2537785-2?pid=4832
Ms. Rosie Andre
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5097.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

newTreeÄrztekammer für WienAMREF - African Medical and Research FoundationSwiss Tropical and Public Health InstituteEuropean Health Forum GasteinAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAlumni Club Medizinische Universität WienCharité International Academy